Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Consumption (Economics) --- Drug abuse --- Economic aspects --- Drug use --- Substance abuse

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Zonder onderwerpscode: economie

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Zonder onderwerpscode: economie

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Discussions about reducing the harms associated with drug use and antidrug policies are often politicized, infused with questionable data, and unproductive. This paper provides a nonpartisan primer on drug use and drug policy in the United States. It aims to bring those new to drug policy up to speed and provide ideas to researchers and potential research funders about how they could make strong contributions to the field.

Drug abuse -- Government policy -- United States. --- Drug control -- United States. --- Narcotic laws -- United States. --- Drug control --- Drug abuse --- Legislation, Drug --- Pharmacy Administration --- Social Control Policies --- Social Control, Formal --- Organization and Administration --- Policy --- Legislation as Topic --- Sociology --- Health Services Administration --- Health Care Economics and Organizations --- Social Sciences --- Anthropology, Education, Sociology and Social Phenomena --- Health Care --- Public Policy --- Drug and Narcotic Control --- Social Welfare & Social Work --- Substance Abuse --- Government policy --- E-books

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Substance use and drug policy are clearly in the national spotlight. Provisional data from the Centers for Disease Control and Prevention suggest that drug overdose deaths in 2018 exceeded 68,000, of which more than 47,000 involved opioids. Although heroin, prescription opioids, and synthetic opioids (such as fentanyl) receive most of the attention, deaths involving methamphetamine and cocaine are both on the rise. In addition, more than 25 percent of the U.S. population lives in states that have passed laws that allow for-profit firms to produce and sell marijuana for nonmedical purposes to adults ages 21 and older. To better understand changes in drug use outcomes and policies, policymakers need to know what is happening in the markets for these substances. This report updates and extends estimates of the number of users, retail expenditures, and amount consumed from 2006 to 2016 for cocaine (including crack), heroin, marijuana, and methamphetamine in the United States, based on a methodology developed by the RAND Corporation for the Office of National Drug Control Policy. The report also includes a discussion of what additional types of data would help quantify the scale of these markets in the future, including the new types of information produced by the legalization of marijuana at the state level.